Canada: Sound Prediction: Insights From Recent Patent Appeal Board Decisions

Last Updated: September 12 2012
Article by Emma Macfarlane

Patent applicants in the life sciences industry often find themselves under pressure to file patent applications before extensive exemplary data has been generated. In Canada, prosecuting such applications can be challenging as the Canadian Intellectual Property Office (CIPO) takes the position that the application should include working examples representative of the scope of the claims and that post-filing data cannot be relied upon to support utility. Three recent Patent Appeal Board decisions (Commissioner's Decision Nos. 1315, 1319 and 1323), however, confirm that such challenges are not insurmountable in view of the uniquely Canadian doctrine of "sound prediction."

Under Canadian law, if the utility of a claimed invention has not been demonstrated at the time an application is filed, then the utility must have been "soundly predicted." For a prediction to be "sound": (1) there must be a factual basis for the prediction; (2) the inventor must have at the date of the patent application, an articulable and "sound" line of reasoning from which the desired result can be inferred from the factual basis; and, (3) there must be proper disclosure (Apotex v. Wellcome Foundation Ltd., 2002 SCC 77).

Most recently, Decision No. 1323 (The New York Blood Center, Inc.) reviewed a Final Action issued for Canadian Patent Application No. 2,308,623, which relates to a method for making antibodies specific to a single form (Fya or Fyb) of the polymorphic "Duffy" protein. Representative claim 1 is directed to a method comprising constructing two syngeneic transgenic mice, one expressing the Fya polymorph and the second expressing the Fyb polymorph, and immunizing one of the mice with cells from the other mouse to produce an antibody specific for the polymorph expressed in the cells used for immunization. Claims 5 and 6 are product-by-process claims directed to a hybridoma cell and a monoclonal antibody, respectively, which include the steps of the method of claim 1. Claim 7 recites an alternative method, which requires constructing only one transgenic mouse and immunizing the mouse with the other Duffy protein polymorph, the origin of which is not specified.

In the Final Action, all claims were rejected under Section 84 of the Patent Rules and Subsection 27(3) of the Patent Act on the basis that they were broader in scope than the teaching in the application. The Board considered two questions in this regard: do the claims go beyond the limits of a sound prediction, and is the disclosure sufficient that the claims do not go beyond what has been described and enabled in the specification. The first question was considered to also bring into play the question of utility, even if this was not explicitly stated in the Final Action.

In assessing whether the utility of the claims was soundly predicted, the Board considered the following. Although the '623 application did not include any working examples of the claimed method, a working example showing a step of the method involving the construction of a transgenic mouse that expressed the Fyb polymorph in the correct (native) conformation was present. The application also described that the Duffy protein was a known and well characterized protein, and that antibodies specific to each polymorph had been made prior to the application, but only by using human sera. Attempts to make monoclonal antibodies using established animal methods had been unsuccessful. The specification further described the reasons why the inventors believed the claimed method would overcome the previously reported failures and result in antibodies specific to the Fya and Fyb polymorphs. The Board also noted that "the Examiner did not provide any evidence of inutility nor a reasoned argument as to why it is not soundly predictable that the method would produce the defined antibodies."

Of note is the fact the Board refused to consider post-filing data provided by the Applicants demonstrating that the method worked as claimed, stating that "after-the-fact confirmation of the utility of a purported invention is not enough to support a predicted but not demonstrated utility."

Nonetheless, with respect to claims 1, 5 and 6, the Board found that the application disclosed both a factual basis and sound line of reasoning to support a sound prediction of utility, and that no scientific rationale had been identified that would weigh against the line of reasoning. In the Board's opinion, however, based on the teaching in the application, the prediction was sound only insofar as the Duffy protein polymorph used for immunization was presented on a murine cell membrane. The Board therefore recommended that claim 7 be amended to include this limitation.

The Board also found that the claims were sufficiently described and enabled by the specification. The Examiner had followed Decision No. 1206 (Institut Pasteur) in rejecting the claims to hybridoma cells and monoclonal antibodies on the basis that no working example of an antibody was present in the application. In Decision No. 1323, however, the Board affirmed its more recent position that making monoclonal antibodies based on a known or fully characterized protein is considered to be a matter of routine for one skilled in the art and, as such, a working example of a monoclonal antibody is no longer required.

Accordingly, with the above-noted amendment to claim 7, all claims were found allowable.

The Board's assessment of whether the utility of the claims was soundly predicted in Decision No. 1323 followed a similar reasoning to that in Decision No. 1315 (MIT and Children's Medical Center Association) and Decision No. 1319 (University of South Florida). In these earlier Decisions, the utility of the entire scope of the claims was found to be soundly predicted even though the working examples in each case represented only one specific embodiment of the broadest claims. In Decision No. 1319, the Board again refused to consider post-filing data presented by the Applicant.

It is noteworthy that in all three of these recent Decisions, the applications relate to well-established technologies and it remains to be seen how the Board will approach cases relating to less established technologies. Collectively, however, these recent Decisions suggest that where working examples are lacking or limited and sound prediction will be relied upon during prosecution to establish utility, then Applicants should ensure that their applications include sufficient teaching, including a description of what is already known in the art and will be relied upon in making the prediction, to establish both a factual basis and a sound line of reasoning within the specification itself. Ideally, the application should also include at least one working example that represents an embodiment that falls within the scope of the broadest claims, or a key step of a claimed method.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
8 Nov 2016, Seminar, Ottawa, Canada

The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.

22 Nov 2016, Seminar, Ottawa, Canada

From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.

7 Dec 2016, Seminar, Ottawa, Canada

Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.